{"id":1196,"date":"2025-01-25T20:34:40","date_gmt":"2025-01-25T20:34:40","guid":{"rendered":"https:\/\/staging.irccs.com\/?post_type=laboratory&p=1196"},"modified":"2025-12-24T10:28:26","modified_gmt":"2025-12-24T09:28:26","slug":"tumor-microenvironment","status":"publish","type":"laboratory","link":"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/","title":{"rendered":"Tumor Microenvironment"},"content":{"rendered":"\n

<\/span>Research topic<\/h2>\n\n\n\n

Semaphorins and Plexins: new targets to \u201cnormalize\u201d the tumor microenvironment ecosystems and to halt tumor progression and metastasis formation.
<\/p>\n\n\n\n

Background<\/h3>\n\n\n\n

The tumor microenvironment (TME) is essential to dynamically regulate cancer progression and, due to its influence to the therapeutic outcome, multiple therapies directed to diverse TME components have been developed in these last years. For instance, immunotherapy that targets different immune cells, by unleashing their anti-tumor properties, has shown encouraging results in different tumor types. It is also well described that tumor vessel \u201cnormalization\u201d represents a remarkably advantageous anti-cancer strategy, reducing tumor hypoxia and being able to favor chemotherapy delivery. Recently it has been shown that combination of compounds that normalize tumor vessels and reprogram cancer-associated fibroblasts (CAFs) with immunotherapeutic drugs enhances their anti-cancer effects. On these bases is critical to identify new normalizing molecules and therapeutic strategies to target simultaneously different TME cell types to efficiently overcome the resistance to the therapies. In these years, several studies have showed that class3 semaphorins (Sema3s) – that act via receptor complexes binding neuropilins 1 and 2 (Nrp1\/2) and transducing the signal by plexins (Plxns) – represent new targets to regulate the TME and cancer growth.<\/p>\n\n\n\n

Research achievements<\/h3>\n\n\n\n

We have uncovered Sema3A as a new vessel normalizing and anti-metastatic agent in mouse models of spontaneous pancreatic neuroendocrine tumors (RIP-Tag2) of cervical carcinomas (HPV16\/E2), and of pancreatic adenocarcinoma (PDAC). Interestingly the re-expression of Sema3A counteracted the resistance to the anti-angiogenic therapies by \u201cnormalizing\u201d <\/em>the tumor vasculature, inhibiting hypoxia and several hypoxia-induced pro-metastatic signaling pathways in pancreatic and cervical cancer models. In collaboration with the Laboratories of Cell Adhesion Dynamics of our Institute, we generated mutant Sema3A protein (Mut-Sema3A) that, binding with high affinity with PlexinA4, efficiently impaired PDAC progression and enhanced the anti-tumor efficacy of chemotherapy. We have previously shown that Sema4A exerted a pro-angiogenic effect enhancing the expression of VEGF-A in macrophages. Our current findings indicated that inhibition of Sema4A-expressing myeloid cells, blocked tumor progression and distal metastases, promoted vessel normalization and reprogrammed the immune cells in PDAC models. Moreover, we showed that genetic and pharmacological PlexnB1 depletion in the TME, by acting on T-cells, hampered tumor growth, metastatic spreading in triple-negative breast cancer (TNBC) models and enhanced the efficacy of anti-PD1 immunotherapy in triple-negative breast cancer (TNBC) models. Together, these observations demonstrated that Semas and Plexins represent suitable targets for new therapies that act on TME able to block more efficiently tumor progression.<\/p>\n\n\n\n

Conclusions and perspectives<\/h3>\n\n\n\n

Our findings provide evidence that Sema3A\/PlexA4 and Sema4A\/PlexnB1 signaling axes regulates the function of several TME cell subtypes (e.g<\/em>., vessels, CAFs and immune cells) and that represents new targets to impair tumor growth and metastasis spreading in different tumor types. Based on these findings the main focus of the laboratory are the following: i) investigation of the molecular mechanisms by which Sema3A and Sema4A modulate the TME cell populations in PDAC and TNBC, by using Single cells RNAseq, Spatial Transcriptomics and Proteomics analysis; ii) identification of the role of different Sema3s and Plexins in modulating the cross-talk among tumor vessels, immune cells, CAFs and nerves both in mouse and human PDAC and TNBC; (iii) evaluation of new therapeutic \u201cimmune\u201d combinatorial strategies by targeting Sema3A\/PlexinA4 and Sema4A\/PlexinB1 signaling axes to enhance the anti-tumor effects of immune check point inhibitors in several mouse models of PDAC and breast cancers; iv) identification of Semas and Plexins as novel targets and predictive biomarkers for immunotherapy in PDAC and TNBC patients.  <\/p>\n\n\n\n

<\/span>Publications<\/h2>\n\n\n\n

At this link<\/a><\/strong>, you can find all the scientific publications of the Principal Investigator.<\/p>\n\n\n\t

\n\t\t\n
\n\t
\n\t\t\t\t\t

Selected publications<\/h2>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\tPlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t

Franzolin G, Brundu S, Cojocaru CF, Curatolo A, Ponzo M, Mastrantonio R, Mihara E, Kumanogoh A, Suga H, Takagi J, Tamagnone L, Giraudo E*. Cancer Immunol Res. 2024 Sep 3;12(9):1286-1301. doi: 10.1158\/2326-6066.CIR-23-0289.*Last and Corresponding author. <\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tMutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t

Brundu S, Napolitano V, Franzolin G, Lo Cascio E, Mastrantonio R, Sardo G, Cascardi E, Verginelli F, Sarnataro S, Gambardella G, Pisacane A, Arcovito A, Boccaccio C, Comoglio PM, Giraudo E*, Tamagnone L. EMBO Mol Med. 2023 Feb 1:e16104. doi: 10.15252 \/ emmm. 202216104. *Co-last and Co-corresponding author. <\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tA rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent.<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t

Noemi Gioelli, Federica Maione, Chiara Camillo, Michela Ghitti, Donatella Valdembri, Noemi Morello, Marie Darche, Lorena Zentilin, Gabriella Cagnoni, Yaqi Qiu, Mauro Giacca, Maurizio Giustetto, Michel Paques, Ilaria Cascone, Giovanna Musco, Luca Tamagnone, Enrico Giraudo*, Guido Serini*. Sci Transl Med. 2018; 10(442):eaah4807. doi: 10.1126\/scitranslmed.aah4807. *Co-Corresponding author and Co-last author.\r\n<\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tHIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t

Yaqi Qiu, Federica Maione, Stefania Capano, Claudia Meda, Orietta Picconi, Serena Brundu, A lberto Pisacane, Anna Sapino, Clelia Palladino, Giovanni Barillari, Paolo Monini, Federico Bussolino, Barbara Ensoli, Cecilia Sgadari, and Enrico Giraudo. Mol Cancer Ther, 2020; 19(12):2476\u201389. doi: 10.1158\/1535-7163.MCT-20-0055. <\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\tSemaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t

Federica Maione, Fabiola Molla, Roberto Latini, Lorena Zentilin, Mauro Giacca, Claudia Meda, Giorgio Seano, Guido Serini, Federico Bussolino and Enrico Giraudo. J. Clin. Invest. 2009; Nov; 119(11): 3356-72. doi: 10.1172\/JCI36308.<\/p>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\t<\/div>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1196","laboratory","type-laboratory","status-publish","hentry"],"acf":[],"yoast_head":"\nTumor Microenvironment - Istituto di Candiolo<\/title>\n<meta name=\"description\" content=\"Research topic Semaphorins and Plexins: new targets to \u201cnormalize\u201d the tumor microenvironment ecosystems and to halt tumor progression and metastasis\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tumor Microenvironment - Istituto di Candiolo\" \/>\n<meta property=\"og:description\" content=\"Research topic Semaphorins and Plexins: new targets to \u201cnormalize\u201d the tumor microenvironment ecosystems and to halt tumor progression and metastasis\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/\" \/>\n<meta property=\"og:site_name\" content=\"Istituto di Candiolo\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/istitutodicandiolo\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-24T09:28:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@fpoirccs\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/\",\"url\":\"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/\",\"name\":\"Tumor Microenvironment - Istituto di Candiolo\",\"isPartOf\":{\"@id\":\"https:\/\/irccs.com\/it\/#website\"},\"datePublished\":\"2025-01-25T20:34:40+00:00\",\"dateModified\":\"2025-12-24T09:28:26+00:00\",\"description\":\"Research topic Semaphorins and Plexins: new targets to \u201cnormalize\u201d the tumor microenvironment ecosystems and to halt tumor progression and metastasis\",\"breadcrumb\":{\"@id\":\"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irccs.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tumor Microenvironment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irccs.com\/it\/#website\",\"url\":\"https:\/\/irccs.com\/it\/\",\"name\":\"INOC\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irccs.com\/it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tumor Microenvironment - Istituto di Candiolo","description":"Research topic Semaphorins and Plexins: new targets to \u201cnormalize\u201d the tumor microenvironment ecosystems and to halt tumor progression and metastasis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/","og_locale":"it_IT","og_type":"article","og_title":"Tumor Microenvironment - Istituto di Candiolo","og_description":"Research topic Semaphorins and Plexins: new targets to \u201cnormalize\u201d the tumor microenvironment ecosystems and to halt tumor progression and metastasis","og_url":"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/","og_site_name":"Istituto di Candiolo","article_publisher":"https:\/\/www.facebook.com\/istitutodicandiolo\/","article_modified_time":"2025-12-24T09:28:26+00:00","twitter_card":"summary_large_image","twitter_site":"@fpoirccs","twitter_misc":{"Tempo di lettura stimato":"4 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/","url":"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/","name":"Tumor Microenvironment - Istituto di Candiolo","isPartOf":{"@id":"https:\/\/irccs.com\/it\/#website"},"datePublished":"2025-01-25T20:34:40+00:00","dateModified":"2025-12-24T09:28:26+00:00","description":"Research topic Semaphorins and Plexins: new targets to \u201cnormalize\u201d the tumor microenvironment ecosystems and to halt tumor progression and metastasis","breadcrumb":{"@id":"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irccs.com\/it\/laboratori\/tumor-microenvironment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irccs.com\/it\/"},{"@type":"ListItem","position":2,"name":"Tumor Microenvironment"}]},{"@type":"WebSite","@id":"https:\/\/irccs.com\/it\/#website","url":"https:\/\/irccs.com\/it\/","name":"INOC","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irccs.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"}]}},"_links":{"self":[{"href":"https:\/\/irccs.com\/it\/wp-json\/wp\/v2\/laboratory\/1196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irccs.com\/it\/wp-json\/wp\/v2\/laboratory"}],"about":[{"href":"https:\/\/irccs.com\/it\/wp-json\/wp\/v2\/types\/laboratory"}],"version-history":[{"count":5,"href":"https:\/\/irccs.com\/it\/wp-json\/wp\/v2\/laboratory\/1196\/revisions"}],"predecessor-version":[{"id":4390,"href":"https:\/\/irccs.com\/it\/wp-json\/wp\/v2\/laboratory\/1196\/revisions\/4390"}],"wp:attachment":[{"href":"https:\/\/irccs.com\/it\/wp-json\/wp\/v2\/media?parent=1196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}